‘Dental Imaging Market Over $1.9 Billion In 2017’ Says Visiongain Report

29 August 2017
Pharma

Visiongain’s new report the Dental Imaging Technology Market Forecasts 2017-2027: Analysis by Medical Application (Diagnostic, Forensic, Cosmetic), Current and Future Technologies (X-ray, CBCT, Intraoral Camera) and End User (Hospitals and Clinics, Academia and Research Institutes) indicates that the global dental imaging market will see over $1.9bn in revenue in 2017.

The lead analyst of the report said:

“In the past three decades, dentistry has witnessed tremendous advances across all of its branches. With these advances, the need for more precise diagnostic tools, especially imaging methods, have become increasingly vital. From the simple intra-oral periapical X-rays, advanced imaging techniques like computed tomography (CT), cone beam computed tomography (CBCT), magnetic resonance imaging (MRI) and ultrasound have also found their place in modern dentistry. The change from analogue to digital radiography has not only made the process simpler and faster, but has also made image storage, manipulation (brightness/contrast, image cropping, etc.) and retrieval easier. Three-dimensional (3-D) imaging has made the complex cranio-facial structures more accessible for examination and also helped in early and accurate diagnosis of deep seated lesions.
The global dental imaging technologies market is expected to witness considerable growth over the forecast period. The main drivers for the growth include technological advances such as 3-D imaging; increasing ageing populations leading to growth in oral diseases; rising oral care awareness and increasing disposable income in emerging economies; growth in cosmetic dentistry; and a shift towards digital dental imaging systems.”

The 152 page report contains 120 tables, charts and graphs that add visual analysis in order to explain developing trends within the dental imaging market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading dental imaging technology submarkets, namely X-ray systems (both intraoral and extraoral), Cone beam computed tomography (CBCT) and intraoral cameras (IOCs). The report also includes forecasts for the applications of dental imaging, including diagnostic and therapeutic use, cosmetic use and forensic use. In addition the report also contains forecasts for the dental imaging market by end-user, including hospitals and clinics, forensic institutes, academia and research institutes.

The 152 page report offers market forecasts and analysis for 4 leading regional and 10 national markets, as well as the rest of the world, rest of Europe and rest of Asia markets. In addition, the report contains a dedicated leading companies’ chapter covering more than 8 companies leading the field in dental imaging technology.

The Dental Imaging Technology Market Forecasts 2017-2027: Analysis by Medical Application (Diagnostic, Forensic, Cosmetic), Current and Future Technologies (X-ray, CBCT, Intraoral Camera) and End User (Hospitals and Clinics, Academia and Research Institutes) report will be of value to anyone who wants to better understand the dental imaging market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the dental imaging industry.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever